Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor

Abstract

IM as a preoperative therapy is feasible and safe for unresectable or metastatic/recurrent GIST that can effectively decrease tumor size, facilitating resection.